---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-001915"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:18:38.627946+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences announces annual meeting results; re-elects directors and ratifies auditor

## Summary
- 40.9% of shares represented at Dec 20, 2024 annual meeting (1,319,986 of 3,227,700 outstanding).
- Directors Steven Kelly and R. Martin Emanuele re-elected to Class I board seats until 2027.
- Ratification of Malone Bailey LLP as independent auditor for FY ending Dec 31, 2024 (1,258,378 for, 57,083 against).

## SEC filing metadata
- accession: 0001640334-24-001915
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033424001915/0001640334-24-001915-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033424001915/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-001915
- JSON: https://secwatch.observer/filing/0001640334-24-001915.json
- Plain text: https://secwatch.observer/filing/0001640334-24-001915.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.